loader2
Partner With Us NRI

Company details

5.13
5.30
4.69
26.40
6M Return -62.46%
1Y Return -19.57%
Mkt Cap.(Cr) 31.95
Volume 159,385
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 159,385

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 14.50 Cr FV: 2.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 28,019.57 -43,282.61
LAST 3M 77,901.94 -49,701.23
LAST 6M 142,324.16 -198,923.20
LAST 12M 202,461.29 -168,761.49
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
Dec 16, 2021 Split 1:5
Aug 09, 2021 Bonus 1:1

Information

  • About Company
  • Company Info
  • Listing Info
15
50.21%
2.7117
24.01%
30.57%
Description
  • Earum Pharmaceuticals Limited was originally incorporated as a private limited company with the name `Earum Pharmaceuticals Private Limited` onJuly 26, 2012. Further, pursuant to Special Resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 10, 2019, the company was converted into a Public Limited Company and consequently the name of the Company was changed from `Earum Pharmaceuticals Private Limited` to `Earum Pharmaceuticals Limited` on January 23, 2019. Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel were the initial subscribers to Memorandum of Association of the Company. The Company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. At present, the company offers around 125 pharmaceutical formulation products, of which around 24 products are marketed under its own brand name, the manufacturing of which is outsourced by the company to third parties. Apart from pharmaceutical formulation products, the company also deals in trading of active pharmaceutical ingredients (API`s) such as Levofloxacin Hemihdrate IP Albendazol IP, Amoxicillin Trihydrate IP etc.

Read More

Registered Address

G1 Ground Floor VR Complex, Nr Sanathal Cross Rd SP RingRd, Ahmedabad, Gujarat, 382210

Tel : 91-79-48402525
Email : info:earumpharma.com
Website : http://www.earumpharma.com

Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Dec
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 542724
NSE Code :
Book Closure Date (Month) : Dec
BSE Group : B
ISIN : INE060601023

ICICIdirect Earum Pharmaceuticals Ltd FAQ

You can buy Earum Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Earum Pharmaceuticals Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 19, 2022 01:51 PM the closing price of Earum Pharmaceuticals Ltd was ₹ 5.18.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 19, 2022 01:51 PM, the market cap of Earum Pharmaceuticals Ltd stood at ₹ 31.95.
The latest PE ratio of Earum Pharmaceuticals Ltd as of May 19, 2022 01:51 PM is 15
The latest PB ratio of Earum Pharmaceuticals Ltd as of May 19, 2022 01:51 PM is 0.51
The 52-week high of Earum Pharmaceuticals Ltd is ₹ 26.40 while the 52-week low is ₹ 4.69 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE